Skip to main content
. 2021 Sep 1;15:722894. doi: 10.3389/fnins.2021.722894

TABLE 1.

Demographic and clinical characteristics for participants.

Variable Patients (n = 30)
Controls (n = 33) t2) p
Baseline Post-rTMS
Age (year) 30.30 ± 4.46 32.03 ± 7.31 0.954 0.345
Sex (female/male) 17 (13) 20 (13) 0.101 0.751
Education (year) 13.20 ± 2.67 12.09 ± 2.04 1.708 0.094
Duration of illness (months) 21.36 ± 4.89
CPED (mg/day)a 584.8 ± 152.39

aCPED, Chlorpromazine equivalent doses (Woods, 2003).